ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

RETRACTED: Downregulation of microRNA-324-3p inhibits lung cancer by blocking the NCAM1-MAPK axis through ALX4 (Retracted Article)

Song, Tieniu*; Zhou, Hui; Wei, Xiaoping; Meng, Yuqi; Guo, Quanwei南方医科大学; 兰州大学; 四川大学
Cancer Gene Therapy2021-5DOI: 10.1038/s41417-020-00231-2
7被引2阅读
引用收藏
分享

摘要

Lung cancer remains the principal cause of cancer-related death worldwide. As microRNAs (miRNAs) are critically involved in lung cancer, we investigated the potential role of miR-324-3p in lung cancer via the ALX4/NCAM1/MAPK axis. The expression of miR-324-3p and ALX4 was detected in clinical samples, and their interaction confirmed by miRNA-targeted luciferase reporter assay. The mechanisms involved in the miR-324-3p-ALX4 interaction in lung cancer cell biological processes were analyzed through gain- and loss-of function approaches. In addition, cultured lung cancer cells were treated with the p38MAPK pathway activator P79350 in order to explore the role of this pathway in the abovementioned axis. Further, a tumor xenograft model in nude mice was constructed to confirm the in vitro findings. miR-324-3p was highly expressed in lung cancer tissues and cells, and inhibited the expression of ALX4 in A549 cells. After confirming the targeted inhibition of ALX4 by miR-324-3p, we showed that this interaction upregulated the expression of NCAM1 and activated the MAPK pathway. The inhibition of miR-324-3p could suppress lung cancer cell invasion, migration, and autophagy, and retarded the growth of subcutaneous tumors in nude mice. Downregulation of ALX4 or NCAM1 overexpression reversed these favorable effects of decreased miR-324-3p. Our study demonstrated the promotive effect of miR-324-3p on the development and progression of lung cancer, thus suggesting a new target for treatment of this devastating disease.

学科与关键词

关键词
MIR-324-3PAUTOPHAGYCELLS
相关
加载中…
  • MIR-4507 Targets TP53 to Facilitate the Malignant Progression of Non-small-cell Lung Cancer
    Zhao, MengYang*; Tang, ZiBo; Wang, YiJun; Ding, JiaoJiao; Guo, Ying; Zhang, Ning; Gao, TianHuiAmerican Journal of Cancer Research, 2021, 12(22): 6600-6609.被引 4
  • miR-4732-3p prevents lung cancer progression via inhibition of the TBX15/TNFSF11 axis
    Li, Pengfei; Li, Ying; Bai, Shuping; Zhang, Yu; Zhao, Ling*Epigenomics, 2023, 15(4).
  • Overexpression of miR-328-5p influences cell growth and migration to promote NSCLC progression by targeting LOXL4
    Ji, Yanzhao; You, Yanting; Wu, Yifen; Wang, Min; He, Qiuxing; Zhou, Xinghong; Chen, Liqian; Sun, Xiaomin; Liu, Yanyan; Fu, Xiuqiong; Kwan, Hiu Yee; Zuo, Qiang; Luo, Ren*; Zhao, Xiaoshan*Annals of Translational Medicine, 2022, 10(6).被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Gene Therapy
发表日期
2021-05
卷期
第 28 卷, 第 5 期
页码
455-470
DOI
10.1038/s41417-020-00231-2
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Bao'an District Scientific and Technology Innovation Bureau [2017JD100]

作者

  • S

    Song, Tieniu (通讯) (第一作者)

    sichuan univ

  • Z

    Zhou, Hui

    2 · lanzhou univ

查看全部 5 位作者收起作者
  • W

    Wei, Xiaoping

    2 · lanzhou univ

  • M

    Meng, Yuqi

    2 · lanzhou univ

  • G

    Guo, Quanwei

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417